44 results on '"Boscolo-Rizzo P"'
Search Results
2. Validity and reliability of the Questionnaire of Olfactory Disorders for Italian-speaking patients with olfactory dysfunction.
- Author
-
Vaira LA, Tirelli G, Rizzo D, Uderzo F, Avanzini F, Trabalzini F, Rivelli N, Burger D, Calabrese L, Solla P, Bussu F, Mayo-Yáñez M, Lechien JR, De Riu G, and Boscolo-Rizzo P
- Subjects
- Humans, Prospective Studies, Reproducibility of Results, Surveys and Questionnaires, Italy, Quality of Life, Olfaction Disorders diagnosis
- Abstract
Objective: To translate and validate an Italian version of the Questionnaire of Olfactory Disorders (IT-QOD)., Materials and Methods: This is a prospective, multicentre study that involved patients with olfactory dysfunction (OD). Both cases and controls underwent administration of the IT-QOD, Sino-Nasal Outcome Test-22 (SNOT-22) and psychophysical evaluation of orthonasal and retronasal olfactory function., Results: The IT-QOD was administered to 96 patients and 38 controls. The Cronbach's alpha exceeded 0.90, indicating satisfactory internal consistency. The test-retest reliability was found to be high for both parosmia (rs = 0.944) and life quality (rs = 0.969). Patients with OD had significantly higher IT-QOD scores compared to healthy individuals (p < 0.001), indicating strong internal validity. The external validity was also satisfactory, as shown by the significant correlation with SNOT-22 (rs = -0.54) and the threshold, discrimination, and identification score (rs = -0.63)., Conclusions: The IT-QOD was demonstrated to be reliable and valid to assess the impact of OD on the quality of life of Italian-speaking patients., (Copyright © 2024 Società Italiana di Otorinolaringoiatria e Chirurgia Cervico-Facciale, Rome, Italy.)
- Published
- 2024
- Full Text
- View/download PDF
3. Effectiveness of Platelet-Rich Plasma for COVID-19-Related Olfactory Dysfunction: A Controlled Study.
- Author
-
Lechien JR, Saussez S, Vaira LA, De Riu G, Boscolo-Rizzo P, Tirelli G, Michel J, and Radulesco T
- Subjects
- Humans, Smell, Research Design, COVID-19 complications, Olfaction Disorders etiology, Olfaction Disorders therapy, Platelet-Rich Plasma
- Abstract
Objective: To investigate the effectiveness of platelet-rich plasma (PRP) injection into the olfactory clefts of coronavirus disease 2019 (COVID-19) patients with persistent olfactory dysfunction (OD)., Study Design: Controlled study., Setting: Multicenter study., Methods: From March 2022 to November 2022, COVID-19 patients with persistent OD were recruited from three European hospitals to undergo PRP injections into the olfactory clefts. Olfactory function was evaluated at baseline and 10 weeks postinjection with the Olfactory Disorder Questionnaire (ODQ) and threshold, discrimination, and identification (TDI) test. Data were compared with a control group of untreated patients., Results: Eighty-one patients who underwent PRP injection and 78 controls were included. Sixty-five PRP patients (80.3%) experienced subjective smell improvement after a mean duration of 3.4 ± 1.9 weeks. The parosmia, life quality statement, and ODQ sub- and total scores significantly decreased from pre- to 10-week postinjection in the PRP group. The TDI sub- and total scores significantly increased 10 weeks postinjection. In controls, the ODQ score did not change over time, while the discrimination, identification, and total TDI scores significantly increase after 10 weeks of follow-up. The 10-week TDI and ODQ scores were significantly better in the PRP group compared with the controls., Conclusion: Patients who underwent PRP injection reported better 10-week subjective and objective smell outcomes than controls. Future randomized-controlled studies using saline injection into the olfactory cleft of controls are needed to determine the superiority of PRP over placebo., (© 2023 American Academy of Otolaryngology-Head and Neck Surgery Foundation.)
- Published
- 2024
- Full Text
- View/download PDF
4. Olfactory and Gustatory Function 3 Years After Mild COVID-19-A Cohort Psychophysical Study.
- Author
-
Boscolo-Rizzo P, Hummel T, Spinato G, Angelo Vaira L, Menini A, Hopkins C, and Tirelli G
- Subjects
- Humans, Smell, SARS-CoV-2, Cohort Studies, Taste Disorders etiology, COVID-19, Olfaction Disorders epidemiology, Olfaction Disorders etiology
- Published
- 2024
- Full Text
- View/download PDF
5. Evaluating long-term smell or taste dysfunction in mildly symptomatic COVID-19 patients: a 3-year follow-up study.
- Author
-
Boscolo-Rizzo P, Spinato G, Hopkins C, Marzolino R, Cavicchia A, Zucchini S, Borsetto D, Lechien JR, Vaira LA, and Tirelli G
- Subjects
- Adult, Humans, Smell, Follow-Up Studies, SARS-CoV-2, RNA, Viral, Taste Disorders epidemiology, Taste Disorders etiology, Taste, COVID-19 complications, COVID-19 epidemiology, Olfaction Disorders diagnosis, Olfaction Disorders epidemiology, Olfaction Disorders etiology
- Abstract
Introduction: No studies have reported data on 3-year prevalence and recovery rates of self-reported COVID-19-related olfactory and gustatory dysfunction. The aim of the present study was to estimate the 3-year prevalence and recovery rate of self-reported COVID-19-related chemosensory dysfunction in a cohort of patients with antecedent mild COVID-19., Methods: This is a prospective observational study, measuring the prevalence of altered sense of smell or taste at follow-up and their variation from baseline, on adult patients consecutively assessed at Treviso and Trieste University Hospitals, who tested positive for SARS-CoV-2 RNA by polymerase chain reaction during March 2020., Results: Overall, out of 403 respondents, 267 patients (66.3%) reported an altered sense of smell or taste (SNOT-22 > 0) at baseline, while 56 (13.9%), 29 (7.2%), and 21 (5.2%) reported such alterations at 6-24 months, 2 years, and 3 years, respectively. Among the 267 patients with COVID-19-associated smell or taste dysfunction at baseline, 246 (92.1%) reported complete resolution at 3 years. Of the patients who still experienced smell or taste dysfunction 2 years after COVID-19, 27.6% and 37.9% recovered completely and partially, respectively, at the 3-year follow-up., Conclusion: Among subjects with antecedent mildly symptomatic SARS-CoV-2 infection, the 3-year prevalence and recovery rate of COVID-19-related alteration in sense of smell or taste was 5% and 92%, respectively. In approximately two-thirds of patients experiencing chemosensory dysfunction still 2 years after COVID-19, it is still possible to observe a delayed complete or partial recovery after a period of 3 years, while the remaining one-third of individuals continues to have unchanged persistent chemosensory alteration., (© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.)
- Published
- 2023
- Full Text
- View/download PDF
6. Olfactory recovery following omicron variant infection: a psychophysical prospective case-control study with six-month follow up.
- Author
-
Vaira LA, Boscolo-Rizzo P, Lechien JR, Mayo-Yáñez M, Petrocelli M, Pistidda L, Salzano G, Maglitto F, Hopkins C, and De Riu G
- Subjects
- Humans, Case-Control Studies, Follow-Up Studies, Smell, Anosmia etiology, Olfaction Disorders epidemiology, Olfaction Disorders etiology
- Abstract
Objective: This study aimed to evaluate the recovery of olfactory function at six months in individuals infected with the coronavirus disease 2019 omicron variant, using psychophysical tests., Methods: A prospective case-control study that included severe acute respiratory syndrome coronavirus-2 patients infected in February and March 2022 was conducted. Patients underwent the Sniffin' Sticks test within 10 days of infection and again after at least 6 months. The olfactory scores were compared with those of a control group., Results: In all, 102 patients and 120 controls were enrolled in the study. At baseline, 26 patients (25.5 per cent) self-reported smell loss. The median threshold, discrimination and identification score was 33.6 (interquartile range, 12.5) for the cases and 36.5 (interquartile range, 4.38) for the controls ( p < 0.001). Based on the threshold, discrimination and identification scores, 12 controls and 34 patients reported olfactory dysfunction ( p < 0.001). Eighty cases underwent re-evaluation at six months; the median threshold, discrimination and identification score was 37.1 (interquartile range, 4.75) with no significant differences compared with the controls., Conclusion: Six months after infection, the prevalence of olfactory dysfunction in patients did not differ significantly from the control population.
- Published
- 2023
- Full Text
- View/download PDF
7. Orthonasal and retronasal odor identification in patients with parosmia.
- Author
-
Li S, Boscolo-Rizzo P, Uderzo F, Tirelli G, Whitcroft KL, and Hummel T
- Subjects
- Male, Humans, Female, Middle Aged, Odorants, Smell physiology, COVID-19, Olfaction Disorders diagnosis, Olfaction Disorders etiology
- Abstract
Objective: To compare retronasal and orthonasal perception in parosmic COVID-19 patients, in order to determine whether COVID-19 has a differential effect on these functions., Methods: Using the Sniffin Sticks test battery orthonasal function was examined for odor threshold, discrimination and identification. Retronasal function was assessed using 20 tasteless aromatized powders. Gustatory function was measured using the Taste Strips test., Results: This study included 177 patients (127 women, 50 men; mean age 45 years), of whom 127 (72%) were hyposmic and 50 (28%) normosmic. Compared to patients without parosmia, parosmic patients performed worse in odor identification for both orthonasal (F = 4.94, p = 0.03) and retronasal tests (F = 11.95, p < 0.01). However, an interaction effect between route of odor identification (orthonasal or retronasal) and parosmia status was found (F = 4.67, p = 0.03): patients with parosmia had relatively lower retronasal scores than patients without parosmia., Conclusion: Our results suggest that COVID-19 may affect the olfactory mucosa differently along the anterior-posterior axis, thereby possibly contributing to the pathophysiology of parosmia. Patients with parosmia also exhibit a higher degree of impairment when odors are presented through the retronasal route during eating and drinking., (© 2023. The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
8. Position paper on olfactory dysfunction: 2023
- Author
-
Whitcroft KL, Altundag A, Balungwe P, Boscolo-Rizzo P, Douglas R, Enecilla MLB, Fjaeldstad AW, Fornazieri MA, Frasnelli J, Gane S, Gudziol H, Gupta N, Haehner A, Hernandez AK, Holbrook EH, Hopkins C, Hsieh JW, Huart C, Husain S, Kamel R, Kim JK, Kobayashi M, Konstantinidis I, Landis BN, Lechner M, Macchi A, Mazal PP, Miri I, Miwa T, Mori E, Mullol J, Mueller CA, Ottaviano G, Patel ZM, Philpott C, Pinto JM, Ramakrishnan VR, Roth Y, Schlosser RJ, Stjärne P, Van Gerven L, Vodicka J, Welge-Luessen A, Wormald PJ, and Hummel T
- Subjects
- Humans, Smell, Quality of Life, Pandemics, Olfaction Disorders diagnosis, Olfaction Disorders therapy, Olfaction Disorders epidemiology, COVID-19
- Abstract
Background: Since publication of the original Position Paper on Olfactory Dysfunction in 2017 (PPOD-17), the personal and societal burden of olfactory disorders has come sharply into focus through the lens of the COVID-19 pandemic. Clinicians, scientists and the public are now more aware of the importance of olfaction, and the impact of its dysfunction on quality of life, nutrition, social relationships and mental health. Accordingly, new basic, translational and clinical research has resulted in significant progress since the PPOD-17. In this updated document, we present and discuss currently available evidence for the diagnosis and management of olfactory dysfunction. Major updates to the current version include, amongst others: new recommendations on olfactory related terminology; new imaging recommendations; new sections on qualitative OD and COVID-19 OD; updated management section. Recommendations were agreed by all co-authors using a modified Delphi process., Conclusions: We have provided an overview of current evidence and expert-agreed recommendations for the definition, investigation, and management of OD. As for our original Position Paper, we hope that this updated document will encourage clinicians and researchers to adopt a common language, and in so doing, increase the methodological quality, consistency, and generalisability of work in this field.
- Published
- 2023
- Full Text
- View/download PDF
9. Psychophysical assessment of olfactory and gustatory function in post-mild COVID-19 patients: A matched case-control study with 2-year follow-up.
- Author
-
Boscolo-Rizzo P, Hummel T, Invitto S, Spinato G, Tomasoni M, Emanuelli E, Tofanelli M, Cavicchia A, Grill V, Vaira LA, Lechien JR, Borsetto D, Polesel J, Dibattista M, Menini A, Hopkins C, and Tirelli G
- Subjects
- Humans, Smell, SARS-CoV-2, Case-Control Studies, Follow-Up Studies, Taste Disorders diagnosis, Taste Disorders epidemiology, COVID-19 diagnosis, COVID-19 epidemiology, Olfaction Disorders diagnosis, Olfaction Disorders epidemiology
- Abstract
Background: The aim of this study was to psychophysically evaluate the prevalence of smell and taste dysfunction 2 years after mildly symptomatic severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection compared to that observed at 1-year follow-up and while considering the background of chemosensory dysfunction in the no-coronavirus disease 2019 (COVID-19) population., Method: This is a prospective case-control study on 93 patients with polymerase chain reaction (PCR)-positive SARS-CoV-2 infection and 93 matched controls. Self-reported olfactory and gustatory dysfunction was assessed by 22-item Sino-Nasal-Outcome Test (SNOT-22), item "Sense of smell or taste." Psychophysical orthonasal and retronasal olfactory function and gustatory performance were estimated using the extended Sniffin' Sticks test battery, 20 powdered tasteless aromas, and taste strips test, respectively. Nasal trigeminal sensitivity was assessed by sniffing a 70% solution of acetic acid., Results: The two psychophysical assessments of chemosensory function took place after a median of 409 days (range, 366-461 days) and 765 days (range, 739-800 days) from the first SARS-CoV-2-positive swab, respectively. At 2-year follow-up, cases exhibited a decrease in the prevalence of olfactory (27.9% vs. 42.0%; absolute difference, -14.0%; 95% confidence interval [CI], -21.8% to -2.6%; p = 0.016) and gustatory dysfunction (14.0% vs. 25.8%; absolute difference, -11.8%; 95% CI, -24.2% to 0.6%; p = 0.098). Subjects with prior COVID-19 were more likely than controls to have an olfactory dysfunction (27.9% vs. 10.8 %; absolute difference, 17.2%; 95% CI, 5.2% to 28.8%) but not gustatory dysfunction (14.0% vs. 9.7%; absolute difference, 4.3%; 95% CI, -5.8% to 14.4% p = 0.496) still 2 years after the infection. Overall, 3.2% of cases were still anosmic 2 years after the infection., Conclusions: Although a proportion of subjects recovered from long-lasting smell/taste dysfunction more than 1 year after COVID-19, cases still exhibited a significant excess of olfactory dysfunction 2 years after SARS-CoV-2 infection when compared to matched controls., (© 2023 ARS-AAOA, LLC.)
- Published
- 2023
- Full Text
- View/download PDF
10. Recovery from olfactory and gustatory dysfunction following COVID-19 acquired during Omicron BA.1 wave in Italy.
- Author
-
Boscolo-Rizzo P, Tirelli G, Meloni P, Hopkins C, Lechien JR, Madeddu G, Bonini P, Gardenal N, Cancellieri E, Lazzarin C, Borsetto D, De Vito A, De Riu G, and Vaira LA
- Subjects
- Humans, Italy epidemiology, SARS-CoV-2, Smell, Taste Disorders epidemiology, Taste Disorders etiology, Prospective Studies, COVID-19 complications, COVID-19 epidemiology, Olfaction Disorders epidemiology, Olfaction Disorders etiology, Olfaction Disorders diagnosis
- Abstract
Background: Despite alterations in the sense of smell and taste have dominated the symptoms of SARS-CoV-2 infection, the prevalence and the severity of self-reporting COVID-19 associated olfactory and gustatory dysfunction has dropped significantly with the advent of the Omicron BA.1 subvariant. However, data on the evolution of Omicron-related chemosensory impairment are still lacking., Objective: The aim of the present study was to estimate the prevalence and the recovery rate of self-reported chemosensory dysfunction 6-month after SARS-CoV-2 infection acquired during the predominance of the Omicron BA.1 subvariant in Italy., Methods: Prospective observational study based on the sino-nasal outcome tool 22 (SNOT-22), item "sense of smell or taste" and additional outcomes conducted in University hospitals and tertiary referral centers in Italy., Results: Of 338 patients with mild-to-moderate COVID-19 completing the baseline survey, 294 (87.0 %) responded to the 6-month follow-up interview. Among them, 101 (34.4 %) and 4 (1.4 %) reported an altered sense of smell or taste at baseline and at 6 months, respectively. Among the 101 patients with COVID-19-associated smell or taste dysfunction during the acute phase of the disease, 97 (96.0 %) reported complete resolution at 6 months. The duration of smell or taste impairment was significantly shorter in vaccinated patients (p = 0.007)., Conclusions: Compared with that observed in subjects infected during the first wave of the pandemic, the recovery rate from chemosensory dysfunctions reported in the present series of patients infected during the predominance of the Omicron BA.1 subvariant was more favorable with a shorter duration being positively influenced by vaccination., Competing Interests: Declaration of competing interest The Authors declare that there is no conflict of interest., (Copyright © 2023. Published by Elsevier Inc.)
- Published
- 2023
- Full Text
- View/download PDF
11. Reply to: It is necessary to assess olfactory and gustatory functions in post-COVID-19 patients due to the omicron variant infection.
- Author
-
Boscolo-Rizzo P, Hummel T, Invitto S, Spinato G, Vaira LA, Lechien JR, Menini A, Hopkins C, and Tirelli G
- Subjects
- Humans, SARS-CoV-2, Smell, Taste Disorders, COVID-19, Olfaction Disorders diagnosis, Olfaction Disorders epidemiology
- Published
- 2023
- Full Text
- View/download PDF
12. Comparison of prevalence and evolution of COVID-19 olfactory disorders in patients infected by D614 (wild) and B.1.1.7. Alpha variant: a brief report.
- Author
-
Lechien JR, Wajsblat S, Horoi M, Boscolo-Rizzo P, Le Bon SD, Vaira LA, and Saussez S
- Subjects
- Humans, SARS-CoV-2, Prevalence, Smell, COVID-19 epidemiology, COVID-19 complications, Olfaction Disorders etiology, Olfaction Disorders complications
- Abstract
Objectives: To investigate the prevalence and the evolution of olfactory disorders (OD) related to coronavirus disease 2019 (COVID-19) in patients infected during the first and the second European waves., Methods: From March 2020 to October 2020, COVID-19 patients with OD were recruited and followed over the 12-month post-infection. The following data were collected: demographic, treatments, vaccination status, and olfactory function. Olfaction was assessed with the Olfactory Disorder Questionnaire (ODQ), and threshold, discrimination, and identification (TDI) test. Outcomes were compared between patients of the first wave (group 1: wild/D614G virus) and the second wave (group 2: B.1.1.7. Alpha variant) at 1-, 3- and 12-month post-infection., Results: Sixty patients completed the evaluations accounting for 33 and 27 patients in group 1 and 2, respectively. The 1-month TDI score (23.7 ± 5.3) was significantly lower in group 2 compared to group 1 (29.8 ± 8.7; p = 0.017). Proportion of normosmic patients at 1-month post-infection was significantly higher in group 1 compared to group 2 (p = 0.009). TDI scores only significantly increased from 1- to 3-month post-infection in anosmic and hyposmic patients. Focusing on There was a negative association between the 1-month ODQ and the 1-month TDI (r
s = - 0.493; p = 0.012). ODQ was a significant predictor of TDI scores at 3- and 12-month post-infection. The 12-month prevalence of parosmia was 60.6% in group 1 and 42.4% in group 2, respectively. There was no significant influence of oral corticosteroid treatment, adherence to an olfactory training and vaccination status on the olfactory outcomes., Conclusions: Patients of the second wave (Alpha B.1.1.7. variant) reported significant higher proportion of psychophysical test abnormalities at 1-month post-infection than patients infected during the first wave (D614G virus)., (© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.)- Published
- 2023
- Full Text
- View/download PDF
13. Subjective Perception of Recovery and Measured Olfactory Function in COVID-19 Patients.
- Author
-
Cancellieri E, Hernandez AK, Degkwitz H, Kahre E, Blankenburg J, Horst TS, Czyborra P, Boscolo-Rizzo P, and Hummel T
- Subjects
- Adult, Humans, Child, Cross-Sectional Studies, Sensory Thresholds, Smell, Anosmia, COVID-19, Olfaction Disorders diagnosis
- Abstract
This cross-sectional study aimed to investigate self-rated olfactory dysfunction in relation to measured olfactory function after partial or complete subjective recovery in individuals with a history of coronavirus disease 2019 (COVID-19) infection. A total of 186 individuals (aged 5-62 years) with a history of COVID-19 infection were included. Visual analogue scale (VAS) ratings for olfactory function (before, during, and after infection) and age-appropriate psychophysical olfactory test scores (odor threshold and odor identification: "Sniffin' Sticks" for adults and both "Sniffin' Sticks" and "U-Sniff" for children) were determined. Participants were assigned to four "age groups" and three "recovery classes" (incomplete recovery, complete recovery, no smell loss). Surprisingly, there were no significant differences in odor threshold and adult identification scores between the "recovery classes". However, children with "incomplete recovery" had lower identification scores than those with "complete recovery" ( p = 0.033) and those with "no smell loss" ( p = 0.022). The pediatric age groups had significantly higher VAS ratings during and after COVID-19 compared to older participants. Older individuals experienced greater magnitude of changes in their sense of smell after COVID-19 infection, but those with parosmia were 3.5 times more likely to report "incomplete recovery" of olfaction after COVID-19. The general prognosis for olfactory recovery after COVID-19 is good but appears to be particularly confounded by the presence of parosmia, leading patients to subjectively report incomplete olfactory recovery. Although it is of high significance to monitor recovery using validated psychophysical olfactory tests, subjective measures of olfaction help provide specific insight, especially for qualitative olfactory dysfunction.
- Published
- 2023
- Full Text
- View/download PDF
14. Parosmia as a predictor of a better olfactory function in COVID-19: a multicentric longitudinal study for upper respiratory tract infections.
- Author
-
Menzel S, Haehner A, Woosch D, Marquardt B, Ressel C, Draf J, Ottaviano G, Boscolo-Rizzo P, Kardashi R, de With K, Hackl Y, and Hummel T
- Subjects
- Humans, Female, Male, Longitudinal Studies, Smell, COVID-19 complications, Olfaction Disorders diagnosis, Olfaction Disorders etiology, Respiratory Tract Infections complications
- Abstract
Purpose: This study aimed to evaluate the course of olfactory dysfunction [OD] due to upper respiratory tract infections [URTI] especially for COVID-19 [C19] in a multicentric design and to investigate possible predictors for the outcome., Methods: In a multicentric study, patients (n = 147, of which 96 were women) with OD due to URTI, including C19 and non-C19 were evaluated at two visits with a standardized medical history and "Sniffin' Sticks" extended psychophysical testing to examine the course and possible predictors for improvement of olfactory function., Results: C19 patients showed better overall olfactory function (p < 0.001) compared to non-C19. Olfactory function (p < 0.001) improved over 3.5 ± 1.2 months in a comparable fashion for C19 and non-C19 comparable over time (p = 0.20) except for a more pronounced improvement of odour threshold (p = 0.03) in C19. C19 patients with parosmia exhibited a higher probability of clinically relevant improvement of odour threshold, a better threshold in the second visit, and tended to have a better TDI-score at the second visit. Further possible predictors for an improving olfactory function were younger age, female gender, and had lower scores in olfactory tests at the first visit., Conclusions: Patients with C19 and non-C19 URTI exhibit a similar improvement over 3-4 months except for the odour threshold, with a better TDI in both visits for C19. For C19 a better prognosis in terms of olfactory recovery was found for younger patients with parosmia and lower olfactory scores at the first visit. Still, for many patients with olfactory loss, an improvement that is experienced as complete may only occur over months and possibly years., (© 2022. The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
15. SARS-CoV-2 Effects on Psychophysical Olfactory Scores: Prospective Study With Evaluation Before and 60-Days After Infection.
- Author
-
Vaira LA, Lechien JR, Salzano G, Maglitto F, Boscolo-Rizzo P, Hopkins C, and De Riu G
- Subjects
- Humans, Smell, SARS-CoV-2, Prospective Studies, Olfaction Disorders diagnosis, Olfaction Disorders etiology, COVID-19 complications
- Abstract
The aim of this study was to prospectively evaluate the olfactory function in a series of individuals infected with SARS-CoV-2 and who had undergone psychophysical olfactory assessment prior to infection. Individuals unexposed to SARS-CoV-2 infection underwent a psychophysical evaluation of smell with the Sniffin' Sticks test. The subjects were followed prospectively and included in the study if they developed SARS-CoV-2 infection with a second test 60 days after recovery. At the 60-day follow-up of the 41 included subjects, 2 (4.9%) self-reported persistent olfactory dysfunction (OD). The differences between TDI scores before and after infection were statistically significant (37 [interquartile range (IQR), 34.25-39.25] vs 34.75 [IQR, 32.25-38]; p = .021). Analyzing the individual olfactory domains, the differences were significant for threshold (T) (9.75 [IQR, 9-11.25] vs 8.25 [IQR, 7.25-10.25]; p = .009) but not for odor discrimination (D) (p = .443) and identification (I) (p = .159). SARS-CoV-2 causes a significant reduction in the olfactory function, in particular affecting the olfactory threshold, even in subjects who do not self-report an OD., (© 2023 American Academy of Otolaryngology--Head and Neck Surgery Foundation.)
- Published
- 2023
- Full Text
- View/download PDF
16. In reference to Intranasal Corticosteroid Treatment on Recovery of Long-Term Olfactory Dysfunction Due to COVID-19.
- Author
-
Vaira LA, De Riu G, Boscolo-Rizzo P, Hopkins C, and Lechien JR
- Subjects
- Humans, Smell, SARS-CoV-2, Adrenal Cortex Hormones therapeutic use, COVID-19 complications, Olfaction Disorders drug therapy, Olfaction Disorders etiology
- Published
- 2023
- Full Text
- View/download PDF
17. Prevalence of olfactory dysfunction in D614G, alpha, delta and omicron waves: a psychophysical case-control study.
- Author
-
Vaira LA, Lechien JR, Deiana G, Salzano G, Maglitto F, Piombino P, Mazzatenta A, Boscolo-Rizzo P, Hopkins C, and De Riu G
- Subjects
- Adult, Humans, Case-Control Studies, Pandemics, Prevalence, COVID-19 epidemiology, COVID-19 physiopathology, COVID-19 virology, Olfaction Disorders diagnosis, Olfaction Disorders epidemiology, Olfaction Disorders virology, SARS-CoV-2
- Abstract
Background: The purpose of this study was to compare the prevalence of olfactory dysfunction (OD) at different stages of the COVID-19 pandemic by evaluating subjects diagnosed with SARS-CoV-2 infection during the Omicron wave with psychophysical tests and comparing the results with those obtained from patients infected during the D614G, Alpha and Delta waves and with those of a control group., Methodology: The study included adult patients diagnosed with SARS-CoV-2 infection. Depending on the time of diagnosis, the subjects were divided into four study groups: D614G; Alpha, Delta and Omicron variant groups. A group of uninfected individuals was used as control. All subjects underwent psychophysical evaluation of the olfactory function with the Connecticut Chemosensory Clinical Research Center olfactory test (D614G and Alpha groups) or the extended version of the Sniffin'Sticks test (Delta, Omicron and control groups)., Results: 372 cases (134 D614G group, 118 Alpha group, 32 in Delta group and 88 Omicron group) were recruited and evaluated within 10 days of infection, alongside 80 controls. Patients self-reported olfactory loss in 72.4% of cases in the D614G group, in 75.4% of cases in the Alpha group, in 65.6% of cases in the Delta group and in 18.1% in the Omicron group. Psychophysical evaluation revealed a prevalence of OD: 80.6%, 83.0%, 65.6% and 36.3% in the D614G, Alpha, Delta and Omicron group respectively. The differences between the D614G, Alpha and Delta groups were not statistically significant. The Omicron group demonstrated a significantly lower prevalence of OD than the other variants but still significantly higher than the controls., Conclusions: During the Omicron wave OD was less prevalent than during the D614G, Alpha and Delta periods. One-third of patients have reduced olfactory function on psychophysical evaluation during the Omicron wave. Our results should be considered with caution as the VOC has not been determined with certainty.
- Published
- 2023
- Full Text
- View/download PDF
18. COVID-19 related persistent olfactory disorders represent an unprecedented challenge.
- Author
-
Vaira LA, De Riu G, Salzano G, Maglitto F, Boscolo-Rizzo P, and Lechien JR
- Subjects
- Humans, Smell, Taste Disorders, COVID-19, Olfaction Disorders etiology
- Abstract
Competing Interests: Declaration of competing interest The authors declare that they have no conflict of interests.
- Published
- 2023
- Full Text
- View/download PDF
19. COVID-19-Related Quantitative and Qualitative Olfactory and Gustatory Dysfunction: Long-Term Prevalence and Recovery Rate.
- Author
-
Boscolo-Rizzo P, Tofanelli M, Zanelli E, Gardenal N, and Tirelli G
- Subjects
- Adult, Humans, Smell, SARS-CoV-2, Prevalence, RNA, Viral, Taste Disorders epidemiology, Taste Disorders etiology, COVID-19 complications, COVID-19 epidemiology, Olfaction Disorders epidemiology, Olfaction Disorders etiology
- Abstract
Introduction: No studies have reported data on 2-year prevalence and recovery rates of self-reported COVID-19-related quantitative and qualitative olfactory and gustatory dysfunction. The aim of the present study was to estimate the 2-year prevalence and recovery rate of self-reported COVID-19-related olfactory and gustatory dysfunction in a cohort of patients with antecedent mild-to-moderate disease., Methods: This is a prospective observational study, measuring the prevalence of altered sense of smell or taste at follow-up and their variation from baseline, on adult patients consecutively assessed at Trieste University Hospital, who tested positive for SARS-CoV-2 RNA by polymerase chain reaction during March 2020., Results: Overall, 174 (68.8%), 53 (20.9%), and 36 (14.2%) of 253 responders reported an altered sense of smell or taste (SNOT-22 >0) at baseline, 12 months, and 24 months, respectively. Among the 174 patients who have complained a COVID-19-associated olfactory or gustatory dysfunction at baseline, 138 (79.3%) reported complete resolution of smell or taste impairment with 17 subjects (9.8%) recovering after more than 1 year after the initial infection, 33 (19.0%) reported a decrease in the severity, and only 3 (1.7%) reported that the symptom was unchanged at the 24-month interview. Twenty subjects (7.9%) complained of at least one qualitative long-term symptom., Conclusion: Two years after the infection, most patients experience a favourable evolution of COVID-19-related olfactory or gustatory dysfunction. A late recovery was observed in 10% of subjects., (© 2022 S. Karger AG, Basel.)
- Published
- 2023
- Full Text
- View/download PDF
20. Parosmia assessment with structured questions and its functional impact in patients with long-term COVID-19-related olfactory dysfunction.
- Author
-
Boscolo-Rizzo P, Hopkins C, Menini A, Dibattista M, Cancellieri E, Gardenal N, Tofanelli M, Valentinotti R, Lechien JR, Vaira LA, and Tirelli G
- Subjects
- Humans, Smell, COVID-19 complications, Olfaction Disorders etiology
- Published
- 2022
- Full Text
- View/download PDF
21. The rate of persistent COVID-19-related chemosensory dysfunctions can be established only after one year.
- Author
-
Vaira LA, De Riu G, Salzano G, Maglitto F, Boscolo-Rizzo P, and Lechien JR
- Subjects
- Humans, Taste Disorders etiology, Anosmia, Ageusia, COVID-19, Olfaction Disorders etiology
- Published
- 2022
- Full Text
- View/download PDF
22. The study of olfactory dysfunction in SARS-CoV-2 variants.
- Author
-
Vaira LA, Boscolo-Rizzo P, Bui Quoc E, Bandekela P, Saussez S, and Lechien JR
- Subjects
- Humans, Prevalence, SARS-CoV-2, Smell, COVID-19, Olfaction Disorders epidemiology
- Published
- 2022
- Full Text
- View/download PDF
23. In response to: Olfactory dysfunction in COVID-19, new insights from a cohort of 353 patients: The ANOSVID study.
- Author
-
Vaira LA, De Riu G, Boscolo-Rizzo P, Hopkins C, and Lechien JR
- Subjects
- Cohort Studies, Humans, SARS-CoV-2, Smell, COVID-19 complications, Olfaction Disorders epidemiology
- Published
- 2022
- Full Text
- View/download PDF
24. Coronavirus disease 2019 (COVID-19)-related smell and taste impairment with widespread diffusion of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) Omicron variant.
- Author
-
Boscolo-Rizzo P, Tirelli G, Meloni P, Hopkins C, Madeddu G, De Vito A, Gardenal N, Valentinotti R, Tofanelli M, Borsetto D, Lechien JR, Polesel J, De Riu G, and Vaira LA
- Subjects
- Dysgeusia epidemiology, Humans, Prospective Studies, SARS-CoV-2, Smell, Taste, COVID-19 epidemiology, Olfaction Disorders
- Abstract
Background: The aim of this study was to estimate the prevalence of self-reported chemosensory dysfunction in a study cohort of subjects who developed a mild-to-moderate coronavirus disease 2019 (COVID-19) in the period from January 17, 2022, to February 4, 2022 (Omicron proxy period) and compared that with a historical series of patients testing positive for severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection between March and April, 2020 (comparator period)., Methods: Prospective study based on the 22-item Sino-Nasal Outcome Tool (SNOT-22), item "sense of smell or taste" and additional outcomes., Results: Patients' characteristics and clinical presentations of COVID-19 were evaluated and compared in 779 patients, 338 of the study cohort and 441 of the historical series. The prevalence of self-reported chemosensory dysfunction during the proxy Omicron period (32.5%; 95% confidence interval [CI], 27.6-37.8) was significantly lower from that during the comparator period (66.9%; 95% CI, 62.3-71.3) (p < 0.001). Nearly one-quarter of patients (24.6%; 95% CI, 20.1-29.5) reported an altered sense of smell during the proxy Omicron period compared to 62.6% (95% CI, 57.9-67.1) during the comparator period (p < 0.001). Similarly, the prevalence of an altered sense of taste dropped to 26.9% (95% CI, 22.3-32.0) during the proxy Omicron period from 57.4% (95% CI, 52.6-62.0) during the comparator period (p < 0.001). The severity of chemosensory dysfunction was lower in the proxy Omicron period compared to the comparator period (p < 0.001)., Conclusion: The prevalence and the severity of COVID-19-associated smell and taste dysfunction has dropped significantly with the advent of the Omicron variant but it still remains above 30%., (© 2022 ARS-AAOA, LLC.)
- Published
- 2022
- Full Text
- View/download PDF
25. Validity and reliability of a french version of the olfactory disorders questionnaire.
- Author
-
Lechien JR, Vaira LA, Le Bon SD, Geerts R, Boscolo-Rizzo P, and Saussez S
- Subjects
- Humans, Reproducibility of Results, Smell, Surveys and Questionnaires, Olfaction Disorders diagnosis, Quality of Life
- Abstract
Objective: To validate a French version of the Olfactory Disorders Questionnaire (Fr-ODQ)., Methods: Patients with olfactory disorder (OD) and controls were enrolled from two medical centers. Individuals completed the Fr-ODQ and the French version of the sinonasal outcome tool-22 (SNOT-22). The extended Sniffin'Sticks procedure was used to test odor Threshold, Discrimination, and Identification (TDI). Cronbach's alpha was used to measure the internal consistency of Fr-ODQ. The reliability and the external validity were evaluated through a test-retest approach and by correlating Fr-ODQ and SNOT-22 scores., Results: Eighty-nine patients with OD and 65 healthy individuals completed the evaluations. The Cronbach's alpha was 0.827, reporting adequate internal consistency. The test-retest reliability was high (r
s = 0.944, p = 0.001). The external validity was adequate regarding the significant correlation between Fr-ODQ and SNOT-22 (rs = 0.498; p = 0.001). Patients with OD reported a significant higher score of Fr-ODQ than healthy individuals (p < 0.001), indicating a high internal validity. The baseline Fr-ODQ significantly improved after 3-month olfactory training, which corroborated the improvement of TDI scores., Conclusion: The Fr-ODQ is the first patient-reported outcome questionnaire validated for French speaking patients. Fr-ODQ is reliable and valid for the evaluation of the olfactory dysfunction and the related impact on quality of life of French-speaking patients., (© 2022. The Author(s).)- Published
- 2022
- Full Text
- View/download PDF
26. Two-Year Prevalence and Recovery Rate of Altered Sense of Smell or Taste in Patients With Mildly Symptomatic COVID-19.
- Author
-
Boscolo-Rizzo P, Fabbris C, Polesel J, Emanuelli E, Tirelli G, Spinato G, and Hopkins C
- Subjects
- Humans, Prevalence, Smell, Taste, Taste Disorders epidemiology, Taste Disorders etiology, COVID-19, Olfaction Disorders epidemiology, Olfaction Disorders etiology
- Published
- 2022
- Full Text
- View/download PDF
27. In Response to Clinical Features of Parosmia Associated with COVID-19 Infection.
- Author
-
Vaira LA, De Riu G, Salzano G, Maglitto F, Boscolo-Rizzo P, and Lechien JR
- Subjects
- Humans, SARS-CoV-2, COVID-19 complications, Olfaction Disorders
- Published
- 2022
- Full Text
- View/download PDF
28. Prevalence of Persistent Olfactory Disorders in Patients With COVID-19: A Psychophysical Case-Control Study With 1-Year Follow-up.
- Author
-
Vaira LA, Salzano G, Le Bon SD, Maglio A, Petrocelli M, Steffens Y, Ligas E, Maglitto F, Lechien JR, Saussez S, Vatrella A, Salzano FA, Boscolo-Rizzo P, Hopkins C, and De Riu G
- Subjects
- Anosmia, Case-Control Studies, Follow-Up Studies, Humans, Prevalence, Smell, COVID-19 epidemiology, Olfaction Disorders epidemiology
- Abstract
The purpose of this multicenter case-control study was to evaluate a group of patients at least 1 year after coronavirus disease 2019 (COVID-19) with Sniffin' Sticks tests and to compare the results with a control population to quantify the potential bias introduced by the underlying prevalence of olfactory dysfunction (OD) in the general population. The study included 170 cases and 170 controls. In the COVID-19 group, 26.5% of cases had OD (anosmia in 4.7%, hyposmia in 21.8%) versus 3.5% in the control group (6 cases of hyposmia). The TDI score (threshold, discrimination, and identification) in the COVID-19 group was significantly lower than in the control group (32.5 [interquartile range, 29-36.5] vs 36.75 [34-39.5], P < .001). The prevalence of OD was significantly higher in the COVID-19 group, confirming that this result is not due to the underlying prevalence of OD in the general population.
- Published
- 2022
- Full Text
- View/download PDF
29. The detection of smell disorder depends on the clinical tools.
- Author
-
Lechien JR, Saussez S, Maniaci A, Boscolo-Rizzo P, and Vaira LA
- Subjects
- Humans, SARS-CoV-2, Smell, Olfaction Disorders diagnosis, Olfaction Disorders etiology
- Published
- 2022
- Full Text
- View/download PDF
30. Self-reported smell and taste recovery in coronavirus disease 2019 patients: a one-year prospective study.
- Author
-
Boscolo-Rizzo P, Guida F, Polesel J, Marcuzzo AV, Antonucci P, Capriotti V, Sacchet E, Cragnolini F, D'Alessandro A, Zanelli E, Marzolino R, Lazzarin C, Tofanelli M, Gardenal N, Borsetto D, Hopkins C, Vaira LA, and Tirelli G
- Subjects
- Humans, Prospective Studies, SARS-CoV-2, Self Report, Smell, Taste, Taste Disorders diagnosis, Taste Disorders epidemiology, Taste Disorders etiology, COVID-19, Olfaction Disorders epidemiology, Olfaction Disorders etiology
- Abstract
Purpose: The aim of the present study was to estimate the 1 year prevalence and recovery rate of self-reported chemosensory dysfunction in a series of subjects with previous mild-to-moderate symptomatic COVID-19., Methods: Prospective study based on the SNOT-22, item "sense of smell or taste" and additional outcomes., Results: 268/315 patients (85.1%) completing the survey at baseline also completed the follow-up interview. The 12 months prevalence of self-reported COVID-19 associated chemosensory dysfunction was 21.3% (95% CI 16.5-26.7%). Of the 187 patients who complained of COVID-19 associated chemosensory dysfunction at baseline, 130 (69.5%; 95% CI 62.4-76.0%) reported complete resolution of smell or taste impairment, 41 (21.9%) reported a decrease in the severity, and 16 (8.6%) reported the symptom was unchanged or worse 1 year after onset. The risk of persistence was higher for patients reporting a baseline SNOT-22 score ≥ 4 (OR = 3.32; 95% CI 1.32-8.36) as well as for those requiring ≥ 22 days for a negative swab (OR = 2.18; 95% CI 1.12-4.27)., Conclusion: A substantial proportion of patients with previous mild-to-moderate symptomatic COVID-19 characterized by new onset of chemosensory dysfunction still complained on altered sense of smell or taste 1 year after the onset., (© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.)
- Published
- 2022
- Full Text
- View/download PDF
31. Analysis of the correlations between the severity of lung involvement and olfactory psychophysical scores in coronavirus disease 2019 (COVID-19) patients.
- Author
-
Amadu AM, Vaira LA, Lechien JR, Scaglione M, Saba L, Lampus ML, Profili SG, Le Bon SD, Salzano G, Maglitto F, Saussez S, Boscolo-Rizzo P, Hopkins C, and De Riu G
- Subjects
- Humans, Lung, SARS-CoV-2, Smell, COVID-19, Olfaction Disorders
- Published
- 2022
- Full Text
- View/download PDF
32. High prevalence of long-term olfactory, gustatory, and chemesthesis dysfunction in post-COVID-19 patients: a matched case-control study with one-year follow-up using a comprehensive psychophysical evaluation.
- Author
-
Boscolo-Rizzo P, Hummel T, Hopkins C, Dibattista M, Menini A, Spinato G, Fabbris C, Emanuelli E, D'Alessandro A, Marzolino R, Zanelli E, Cancellieri E, Cargnelutti K, Fadda S, Borsetto D, Vaira LA, Gardenal N, Polesel J, and Tirelli G
- Subjects
- Case-Control Studies, Follow-Up Studies, Humans, Prevalence, SARS-CoV-2, Smell, Taste Disorders epidemiology, Taste Disorders etiology, COVID-19, Olfaction Disorders epidemiology, Olfaction Disorders etiology
- Abstract
Background: Using an age and gender matched-pair case-control study, we aimed to estimate the long-term prevalence of psychophysical olfactory, gustatory , and chemesthesis impairment at least one year after SARS-CoV-2 infection considering the background of chemosensory dysfunction in non-COVID-19 population., Methodology: This case-controlled study included 100 patients who were home-isolated for mildly symptomatic COVID-19 between March and April 2020. One control regularly tested for SARS-CoV-2 infection and always tested negative was matched to each case according to gender and age. Chemosensory function was investigated by a comprehensive psychophysical evaluation including ortho- and retronasal olfaction and an extensive assessment of gustatory function. Differences in chemosensory parameters were evaluated through either Fisher’s exact test or Kruskal-Wallis test., Results: The psychophysical assessment of chemosensory function took place after a median of 401 days from the first SARS-CoV-2 positive swab. The evaluation of orthonasal smell identified 46% and 10% of cases and controls, respectively, having olfactory dysfunction, with 7% of COVID-19 cases being functionally anosmic. Testing of gustatory function revealed a 27% of cases versus 10% of controls showing a gustatory impairment. Nasal trigeminal sensitivity was significantly lower in cases compared to controls. Persistent chemosensory impairment was associated with emotional distress and depression., Conclusion: More than one year after the onset of COVID-19, cases exhibited an excess of olfactory, gustatory , and chemesthesis disturbances compared to matched-pair controls with these symptoms being associated to emotional distress and depression.
- Published
- 2021
- Full Text
- View/download PDF
33. Six-month smell and taste recovery rates in coronavirus disease 2019 patients: a prospective psychophysical study.
- Author
-
Petrocelli M, Cutrupi S, Salzano G, Maglitto F, Salzano FA, Lechien JR, Saussez S, Boscolo-Rizzo P, De Riu G, and Vaira LA
- Subjects
- Adult, Ageusia epidemiology, Anosmia epidemiology, COVID-19 diagnosis, COVID-19 psychology, COVID-19 virology, Female, Follow-Up Studies, Humans, Incidence, Italy epidemiology, Male, Middle Aged, Olfaction Disorders diagnosis, Prospective Studies, SARS-CoV-2 isolation & purification, Smell physiology, Taste physiology, Taste Disorders diagnosis, COVID-19 complications, Olfaction Disorders etiology, Psychophysics methods, Recovery of Function physiology, Taste Disorders etiology
- Abstract
Background: The long-term recovery rate for coronavirus disease 2019 related chemosensory disturbances has not yet been clarified., Methods: Olfactory and gustatory functions were assessed with psychophysical tests in patients in the first seven days from coronavirus disease 2019 onset and one, two, three and six months after the first evaluation., Results: A total of 300 patients completed the study. The improvement in olfactory function was significant at the two-month follow up. At the end of the observation period, 27 per cent of the patients still experienced a persistent olfactory disturbance, including anosmia in 5 per cent of cases. As for taste, the improvement in the psychophysical scores was significant only between the baseline and the 30-day control. At the 6-month evaluation, 10 per cent of the patients presented with a persistent gustatory disturbance with an incidence of complete ageusia of 1 per cent., Conclusion: Six months after the onset of coronavirus disease 2019, about 6 per cent of patients still had a severe persistent olfactory or gustatory disturbance.
- Published
- 2021
- Full Text
- View/download PDF
34. Understanding COVID-19-Related Olfactory Dysfunction-Reply.
- Author
-
Boscolo-Rizzo P, Borsetto D, and Hopkins C
- Subjects
- Humans, SARS-CoV-2, Smell, Taste Disorders, COVID-19, Olfaction Disorders etiology
- Published
- 2021
- Full Text
- View/download PDF
35. Six-Month Psychophysical Evaluation of Olfactory Dysfunction in Patients with COVID-19.
- Author
-
Boscolo-Rizzo P, Menegaldo A, Fabbris C, Spinato G, Borsetto D, Vaira LA, Calvanese L, Pettorelli A, Sonego M, Frezza D, Bertolin A, Cestaro W, Rigoli R, D'Alessandro A, Tirelli G, Da Mosto MC, Menini A, Polesel J, and Hopkins C
- Subjects
- Adult, Aged, COVID-19 diagnosis, Female, Humans, Male, Middle Aged, Olfaction Disorders diagnosis, Prospective Studies, Psychophysics, SARS-CoV-2 isolation & purification, Self Report, Smell, Taste, COVID-19 complications, COVID-19 physiopathology, Olfaction Disorders etiology, Olfaction Disorders physiopathology
- Abstract
This study prospectively assessed the 6-month prevalence of self-reported and psychophysically measured olfactory dysfunction in subjects with mild-to-moderate COVID-19. Self-reported smell or taste impairment was prospectively evaluated by SNOT-22 at diagnosis, 4-week, 8-week, and 6-month. At 6 months from the diagnosis, psychophysical evaluation of olfactory function was also performed using the 34-item culturally adapted University of Pennsylvania Smell Identification Test (CA-UPSIT). 145 completed both the 6-month subjective and psychophysical olfactory evaluation. According to CA-UPSIT, 87 subjects (60.0%) exhibited some smell dysfunction, with 10 patients being anosmic (6.9%) and seven being severely microsmic (4.8%). At the time CA-UPSIT was administered, a weak correlation was observed between the self-reported alteration of the sense of smell or taste and olfactory test scores (Spearman's r = -0.26). Among 112 patients who self-reported normal sense of smell at last follow-up, CA-UPSIT revealed normal smell in 46 (41.1%), mild microsmia in 46 (41.1%), moderate microsmia in 11 (9.8%), severe microsmia in 3 (2.3%), and anosmia in 6 (5.4%) patients; however, of those patients self-reporting normal smell but who were found to have hypofunction on testing, 62 out of 66 had a self-reported reduction in sense of smell or taste at an earlier time point. Despite most patients report a subjectively normal sense of smell, we observed a high percentage of persistent smell dysfunction at 6 months from the diagnosis of syndrome coronavirus 2 (SARS-CoV-2) infection, with 11.7% of patients being anosmic or severely microsmic. These data highlight a significant long-term rate of smell alteration in patients with previous SARS-COV-2 infection., (© The Author(s) 2021. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.)
- Published
- 2021
- Full Text
- View/download PDF
36. Self-reported alteration of sense of smell or taste in patients with COVID-19: a systematic review and meta-analysis on 3563 patients.
- Author
-
Borsetto D, Hopkins C, Philips V, Obholzer R, Tirelli G, Polesel J, and Boscolo-Rizzo P
- Subjects
- Betacoronavirus, COVID-19, Humans, Pandemics, SARS-CoV-2, Self Report, Smell, Taste, Coronavirus Infections complications, Olfaction Disorders virology, Pneumonia, Viral complications, Taste Disorders virology
- Abstract
Background: Emerging reports suggest that new onset of smell or taste loss are potential early clinical markers of SARS-CoV-2 infection, but it remains unclear as to what extent. Therefore, the purpose of this study is to systematically assess the prevalence of self-reported altered sense of smell or taste in patients with confirmed SARS-CoV-2 infection, overcoming the limitations of individual studies by meta-analysis of pooled data., Methods: The databases Medline, Embase, Web of Science, Scopus and MedRxiv's set were searched from inception to the 4th May 2020. This study was conducted following the PRISMA checklist., Results: 18 studies met the eligibility criteria out of the 171 initially screened citations. The overall prevalence of alteration of the sense of smell or taste was 47% , but estimates were 31% and 67% in severe and mild-to-moderate symptomatic patients, respec- tively. The loss of smell and taste preceded other symptoms in 20% of cases and it was concomitant in 28%., Conclusions: Based on this meta-analysis, we recommend self-isolation and testing, where possible, for patients complaining smell or taste impairment during COVID-19 pandemic in order to prevent spread of disease and propose the inclusion of loss of smell and taste as recognized symptoms of SARS-CoV-2 in the World Health Organization and other relevant regulatory body's lists.
- Published
- 2020
- Full Text
- View/download PDF
37. Predominance of an altered sense of smell or taste among long-lasting symptoms in patients with mildly symptomatic COVID-19.
- Author
-
Boscolo-Rizzo P, Polesel J, Spinato G, Menegaldo A, Fabbris C, Calvanese L, Borsetto D, and Hopkins C
- Subjects
- Betacoronavirus, COVID-19, Humans, Pandemics, SARS-CoV-2, Smell, Taste, Coronavirus Infections complications, Olfaction Disorders virology, Pneumonia, Viral complications, Taste Disorders virology
- Abstract
There is mounting evidence that a new onset of altered sense of smell or taste is related to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. In order to allow patients to recognize symptoms indicative of SARS-CoV-2 infection and self-isolate at the earliest opportunity, self-reported loss of smell and taste have greater value in controlling disease transmis- sion than psychophysical testing, which is not widely available outside of highly specialized clinics.
- Published
- 2020
- Full Text
- View/download PDF
38. Challenges in interpreting the diagnostic performance of symptoms to predict COVID-19 status: The case of anosmia.
- Author
-
Boscolo-Rizzo P, Borsetto D, Hopkins C, and Polesel J
- Subjects
- COVID-19, COVID-19 Testing, Coronavirus Infections complications, Humans, Olfaction Disorders diagnosis, Pandemics, Pneumonia, Viral complications, SARS-CoV-2, Sensitivity and Specificity, Taste Disorders diagnosis, Betacoronavirus, Clinical Laboratory Techniques methods, Coronavirus Infections diagnosis, Olfaction Disorders virology, Pneumonia, Viral diagnosis, Taste Disorders virology
- Published
- 2020
- Full Text
- View/download PDF
39. New onset of loss of smell or taste in household contacts of home-isolated SARS-CoV-2-positive subjects.
- Author
-
Boscolo-Rizzo P, Borsetto D, Spinato G, Fabbris C, Menegaldo A, Gaudioso P, Nicolai P, Tirelli G, Da Mosto MC, Rigoli R, Polesel J, and Hopkins C
- Subjects
- Betacoronavirus, COVID-19, Contact Tracing, Coronavirus Infections, Cross-Sectional Studies, Dysgeusia diagnosis, Dysgeusia epidemiology, Family, Female, Humans, Male, Olfaction Disorders diagnosis, Olfaction Disorders virology, Pandemics, Pneumonia, Viral, Prevalence, SARS-CoV-2, Smell, Taste Disorders diagnosis, Taste Disorders epidemiology, Taste Disorders virology, Dysgeusia etiology, Olfaction Disorders etiology, Taste physiology, Taste Disorders etiology
- Abstract
Purpose: To estimate the prevalence of smell or taste impairment in household contacts of mildly symptomatic home-isolated SARS-CoV-2-positive patients., Methods: Cross-sectional study based on ad hoc questions., Results: Of 214 mildly symptomatic COVID-19 patients managed at home under self-isolation, 179 reported to have at least one household contact, with the total number of no study participants contacts being 296. Among 175 household contacts not tested for SARS-CoV-2 infection, 67 (38.3%) had SARS-CoV-2 compatible symptoms, 39 (22.3%) had loss of smell or taste with 7 (4.0%) having loss of smell or taste in the absence of other symptoms. The prevalence of smell or taste impairment was 1.5% in patients tested negative compared to 63.0% of those tested positive for SARS-CoV-2 (p < 0.001)., Conclusion: Smell or taste impairment are quite common in not-tested household contacts of mildly symptomatic home-isolated SARS-CoV-2-positive patients. This should be taken into account when estimating the burden of loss of sense of smell and taste during COVID-19 pandemic, and further highlights the value of loss of sense of smell and taste as a marker of infection.
- Published
- 2020
- Full Text
- View/download PDF
40. Evolution of Altered Sense of Smell or Taste in Patients With Mildly Symptomatic COVID-19.
- Author
-
Boscolo-Rizzo P, Borsetto D, Fabbris C, Spinato G, Frezza D, Menegaldo A, Mularoni F, Gaudioso P, Cazzador D, Marciani S, Frasconi S, Ferraro M, Berro C, Varago C, Nicolai P, Tirelli G, Da Mosto MC, Obholzer R, Rigoli R, Polesel J, and Hopkins C
- Subjects
- Adult, Aged, Aged, 80 and over, Cross-Sectional Studies, Female, Humans, Italy epidemiology, Male, Middle Aged, Prevalence, Prospective Studies, Severity of Illness Index, Young Adult, COVID-19 complications, Olfaction Disorders epidemiology, Olfaction Disorders virology, Taste Disorders epidemiology, Taste Disorders virology
- Abstract
Importance: An altered sense of smell and taste has been reported to be associated with coronavirus disease 2019 (COVID-19). To understand the evolution of these symptoms during the course of the disease is important to identify patients with persistent loss of smell or taste and estimate the impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection on the burden of olfactory and gustative dysfunctions., Objective: To evaluate the evolution of the loss of sense of smell and taste in a case series of mildly symptomatic patients with SARS-CoV-2 infection., Design, Setting, and Participants: This cross-sectional survey-based study included 202 mildly symptomatic adults (≥18 years) consecutively assessed at Treviso Regional Hospital, Italy, between March 19 and March 22, 2020, who tested positive for SARS-CoV-2 RNA by polymerase chain reaction on nasopharyngeal and throat swabs., Main Outcomes and Measures: Prevalence of altered sense of smell and taste at follow-up and their variation from baseline., Results: Of 202 patients completing the survey at baseline, 187 (92.6%) also completed the follow-up survey (103 [55.1%] women; median age, 56 years). The evaluation of the evolution of altered sense of smell or taste in the 113 patients reporting sudden onset of these symptoms at baseline showed that 55 patients (48.7%; 95% CI, 39.2-58.3) reported complete resolution of smell or taste impairment, 46 (40.7%; 95% CI, 31.6-50.4) reported an improvement in the severity, and only 12 (10.6%; 95% CI, 5.6-17.8) reported the symptom was unchanged or worse. Persistent loss of smell or taste was not associated with persistent SARS-CoV-2 infection., Conclusions and Relevance: At 4 weeks from the onset, 89% of the SARS-CoV-2-positive mildly symptomatic patients who had had a sudden onset of altered sense of smell or taste experienced a complete resolution or improvement of these symptoms. Persistent loss of smell or taste was not associated with persistent SARS-CoV-2 infection.
- Published
- 2020
- Full Text
- View/download PDF
41. Alterations in Smell or Taste in Mildly Symptomatic Outpatients With SARS-CoV-2 Infection.
- Author
-
Spinato G, Fabbris C, Polesel J, Cazzador D, Borsetto D, Hopkins C, and Boscolo-Rizzo P
- Subjects
- COVID-19, Coronavirus Infections physiopathology, Humans, Pandemics, Pneumonia, Viral physiopathology, SARS-CoV-2, Smell, Taste, Betacoronavirus, Coronavirus Infections complications, Olfaction Disorders etiology, Pneumonia, Viral complications, Taste Disorders etiology
- Published
- 2020
- Full Text
- View/download PDF
42. Subjective Perception of Recovery and Measured Olfactory Function in COVID-19 Patients
- Author
-
Emilia Cancellieri, Anna Kristina Hernandez, Helena Degkwitz, Elisabeth Kahre, Judith Blankenburg, Theresa S. Horst, Paula Czyborra, Paolo Boscolo-Rizzo, and Thomas Hummel
- Subjects
smell ,olfaction disorders ,COVID-19 ,sensory threshold ,self-report ,parosmia ,Microbiology ,QR1-502 - Abstract
This cross-sectional study aimed to investigate self-rated olfactory dysfunction in relation to measured olfactory function after partial or complete subjective recovery in individuals with a history of coronavirus disease 2019 (COVID-19) infection. A total of 186 individuals (aged 5–62 years) with a history of COVID-19 infection were included. Visual analogue scale (VAS) ratings for olfactory function (before, during, and after infection) and age-appropriate psychophysical olfactory test scores (odor threshold and odor identification: “Sniffin’ Sticks” for adults and both “Sniffin’ Sticks” and “U-Sniff” for children) were determined. Participants were assigned to four “age groups” and three “recovery classes” (incomplete recovery, complete recovery, no smell loss). Surprisingly, there were no significant differences in odor threshold and adult identification scores between the “recovery classes”. However, children with “incomplete recovery” had lower identification scores than those with “complete recovery” (p = 0.033) and those with “no smell loss” (p = 0.022). The pediatric age groups had significantly higher VAS ratings during and after COVID-19 compared to older participants. Older individuals experienced greater magnitude of changes in their sense of smell after COVID-19 infection, but those with parosmia were 3.5 times more likely to report “incomplete recovery" of olfaction after COVID-19. The general prognosis for olfactory recovery after COVID-19 is good but appears to be particularly confounded by the presence of parosmia, leading patients to subjectively report incomplete olfactory recovery. Although it is of high significance to monitor recovery using validated psychophysical olfactory tests, subjective measures of olfaction help provide specific insight, especially for qualitative olfactory dysfunction.
- Published
- 2023
- Full Text
- View/download PDF
43. Six-month smell and taste recovery rates in coronavirus disease 2019 patients: a prospective psychophysical study
- Author
-
G De Riu, Luigi Angelo Vaira, Jerome R. Lechien, Paolo Boscolo-Rizzo, S Cutrupi, Fabio Maglitto, Francesco Antonio Salzano, Giovanni Salzano, Sven Saussez, Marzia Petrocelli, Petrocelli, M, Cutrupi, S, Salzano, G, Maglitto, F, A Salzano, F, R Lechien, J, Saussez, S, Boscolo-Rizzo, P, De Riu, G, and A Vaira, L
- Subjects
Adult ,Male ,Olfactory system ,Pediatrics ,medicine.medical_specialty ,Taste ,Coronavirus disease 2019 (COVID-19) ,Anosmia ,medicine.disease_cause ,Olfaction Disorders ,Taste Disorders ,Olfaction Disorder ,Psychophysics ,medicine ,Humans ,Prospective Studies ,Prospective cohort study ,Coronavirus ,SARS-CoV-2 ,business.industry ,Incidence ,Incidence (epidemiology) ,Main Articles ,COVID-19 ,Recovery of Function ,General Medicine ,Middle Aged ,Ageusia ,Smell ,Italy ,Otorhinolaryngology ,Female ,medicine.symptom ,business ,Follow-Up Studies - Abstract
BackgroundThe long-term recovery rate for coronavirus disease 2019 related chemosensory disturbances has not yet been clarified.MethodsOlfactory and gustatory functions were assessed with psychophysical tests in patients in the first seven days from coronavirus disease 2019 onset and one, two, three and six months after the first evaluation.ResultsA total of 300 patients completed the study. The improvement in olfactory function was significant at the two-month follow up. At the end of the observation period, 27 per cent of the patients still experienced a persistent olfactory disturbance, including anosmia in 5 per cent of cases. As for taste, the improvement in the psychophysical scores was significant only between the baseline and the 30-day control. At the 6-month evaluation, 10 per cent of the patients presented with a persistent gustatory disturbance with an incidence of complete ageusia of 1 per cent.ConclusionSix months after the onset of coronavirus disease 2019, about 6 per cent of patients still had a severe persistent olfactory or gustatory disturbance.
- Published
- 2021
44. Self-reported alteration of sense of smell or taste in patients with COVID-19: a systematic review and meta-analysis on 3563 patients
- Author
-
D. Borsetto, C. Hopkins, V. Philips, R. Obholzer, G. Tirelli, J. Polesel, L. Calvanese, P. Boscolo-Rizzo, Borsetto, D, Hopkins, C, Philips, V, Obholzer, R, Tirelli, G, Polesel, J, and Boscolo-Rizzo, P
- Subjects
medicine.medical_specialty ,Taste ,Anosmia ,Pneumonia, Viral ,MEDLINE ,Olfaction ,Disease ,Taste lo ,03 medical and health sciences ,Betacoronavirus ,Olfaction Disorders ,Taste Disorders ,0302 clinical medicine ,Olfaction Disorder ,Internal medicine ,medicine ,Smell lo ,Humans ,Viral ,030223 otorhinolaryngology ,Pandemics ,Betacoronaviru ,Pandemic ,business.industry ,Coronavirus Infection ,SARS-CoV-2 ,Smell loss ,COVID-19 ,General Medicine ,Pneumonia ,Ageusia ,Checklist ,Smell ,Otorhinolaryngology ,Meta-analysis ,Self Report ,medicine.symptom ,business ,Coronavirus Infections ,Covid-19 ,Taste loss ,Human - Abstract
Background Emerging reports suggest that new onset of smell or taste loss are potential early clinical markers of SARS-CoV-2 infection, but it remains unclear as to what extent. Therefore, the purpose of this study is to systematically assess the prevalence of self-reported altered sense of smell or taste in patients with confirmed SARS-CoV-2 infection, overcoming the limitations of individual studies by meta-analysis of pooled data. Methods The databases Medline, Embase, Web of Science, Scopus and MedRxiv's set were searched from inception to the 4th May 2020. This study was conducted following the PRISMA checklist. Results 18 studies met the eligibility criteria out of the 171 initially screened citations. The overall prevalence of alteration of the sense of smell or taste was 47% , but estimates were 31% and 67% in severe and mild-to-moderate symptomatic patients, respec- tively. The loss of smell and taste preceded other symptoms in 20% of cases and it was concomitant in 28%. Conclusions Based on this meta-analysis, we recommend self-isolation and testing, where possible, for patients complaining smell or taste impairment during COVID-19 pandemic in order to prevent spread of disease and propose the inclusion of loss of smell and taste as recognized symptoms of SARS-CoV-2 in the World Health Organization and other relevant regulatory body's lists.
- Published
- 2020
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.